Maxele Advisors’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Buy
+2,658
New +$387K 0.27% 76
2025
Q4
$401K Hold
2,800
0.33% 64
2025
Q3
$430K Sell
2,800
-25
-0.9% -$3.9K 0.37% 61
2025
Q2
$450K Buy
2,825
+53
+2% +$8.65K 0.39% 58
2025
Q1
$472K Buy
2,772
+762
+38% +$128K 0.46% 52
2024
Q4
$337K Buy
+2,010
New +$342K 0.32% 70
2022
Q3
$253K Sell
2,005
-48
-2% -$6.82K 0.43% 66
2022
Q2
$295K Sell
2,053
-7
-0.3% -$1.05K 0.46% 62
2022
Q1
$315K Sell
2,060
-45
-2% -$7.04K 0.39% 65
2021
Q4
$344K Buy
+2,105
New +$313K 0.4% 65

Other funds holding PG

Maxele Advisors's PG Position: Q2 2026 in Review

Maxele Advisors opened a new position in Procter & Gamble (PG) in Q2 2026: 2,658 shares worth $390K. The stake represents 0.27% of the portfolio and ranks #76 among its holdings. This is a return to the name: Maxele Advisors previously reported a position in PG as recently as Q4 2025.

Maxele Advisors first reported a position in PG in Q4 2021 and has held it in 10 quarters since. The position peaked at $472K in Q1 2025. 4,015 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Maxele Advisors held 2,658 shares of Procter & Gamble worth $390K as of Q2 2026.
  • Procter & Gamble was a new Maxele Advisors position in Q2 2026.
  • Procter & Gamble made up 0.27% of Maxele Advisors's portfolio in Q2 2026, its #76 holding.
  • Maxele Advisors first reported a position in Procter & Gamble in Q4 2021 and has held it in 10 quarters since.
  • Maxele Advisors's Procter & Gamble position peaked at $472K in Q1 2025.
  • 4,015 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Maxele Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.